Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Psilocybin program

Recent news which mentions Psilocybin program

< Previous 1 2 Next >
Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
Tickers NEWS OPTHF
Tags Psychedelics Research Legal Management
From Benzinga
Psilocybin Mushrooms For Sale: Is It Legal Anywhere In America?
Tickers CMPS
Tags Psychedelics Reform Management Psychedelics
From Benzinga
Incannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In Australia
Tickers IXHL NEWS
Tags Legal IXHL News
From Benzinga
Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
Tickers ATAI BRAXF CMND CMPS
Tags IXHL MNMD ATAI
From Benzinga
Alternative Treatment For Bipolar II Depression: Psilocybin Safe And Effective, AMA Study Finds
Tickers CMPS
Tags CMPS General News
From Benzinga
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
Tickers ATAI CMND CMPS CYBN
Tags Markets ENVB TRUFF
From Benzinga
Global Psychedelics: Australia's Prescription Guidelines, New Zealand's Meth Addiction Treatment
Tags Addiction Treatment Methamphetamine Use Disorder Markets
From Benzinga
Nasdaq On Horizon For Psyence Group: Psilocybin Therapeutics Division Forms New Business Combination
Tickers NCAC
Tags Contracts News Business Combination
From Benzinga
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
Tickers AWKNF CMPS
Tags Ketamine/Assisted Therapy News CMPS
From Benzinga
Canada To Australia: New MDMA & Psilocybin Shipment On Its Way For Legal Therapeutic Market
Tickers PMBHF
Tags Markets Psychedelics Rescheduling News
From Benzinga
COMPASS Pathways Q3 2023 Results: Cash Injection To Sustain Phase 3 Psilocybin Program
Tickers CMPS
Tags Cannabis Markets Market News
From Benzinga
Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find
Tickers CYBN
Tags major depressive disorder Psychedelics Market News
From Benzinga
EXCLUSIVE: Becoming Compliant In Today's Legal Psychedelics Markets With Allay Consulting
Tags Market News Cannabis Psychedelic/Assisted Therapies
From Benzinga
EXCLUSIVE - Canada Approves First Legal Medical Psilocybin Access: Veteran To Undergo Apex's Macrodose Therapy
Tags Psychedelics Apex Labs Global
From Benzinga
Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression
Tickers CYBN DMTTF
Tags CYBN News DMTTF
From Benzinga
Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives, Details Here
Tickers ENVB
Tags Market News Markets ENVB
From Benzinga
Congress To Discuss New Bill Banning Federal Intervention In States Where Psilocybin Is Legal
Tags Markets Politics General
From Benzinga
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
Tickers ATAI AWKNF CMND CMPS
Tags AWKNF Psychedelics DRUG
From Benzinga
Psychedelics Reform Update: CA Bill's Final Vote, MA 2024 Legalization Ballot, HI Task Force, OR Funding And More
Tags Market News Cannabis Markets
From Benzinga
Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression
Tickers CMPS
Tags Small Cap Rumors treatment/resistant depression
From Benzinga
Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, New Usona Phase 2 Trial Shows
Tags Markets Guidance News
From Benzinga
Red Light Holland's Q1 2024 Performance: Revenue Soars 53% And Solid Cash Balance
Tickers TRUFF
Tags Cannabis Market News Psilocybin program
From Benzinga
From Ice Rink To Healing Haven: Former NHL Player Sets Up Psilocybin Therapy Center In Colorado
Tags News mental health Psychedelics
From Benzinga
Up To $285M In Financing: COMPASS Pathways' Private Placement Backed By 'Select Group' Of Investors
Tickers CMPS
Tags News Management CMPS
From Benzinga
Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing
Tickers FLHLF JAQC
Tags JAQC Guidance Markets
From Benzinga
Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs
Tickers MYCOF
Tags Market News smoke cessation Cannabis
From Benzinga
COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And 'Strong Progress Across The Business'
Tickers CMPS HTGC
Tags Psychedelics Small Cap financial results
From Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
Tickers ATAI AWKNF CMPS CYBN
Tags Market News PSIL SCTL
From Benzinga
Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player
Tickers MGCLF OPTHF TRUFF
Tags OPTHF Psychedelics Import Psychedelics
From Benzinga
Jamaica Launches Organic Psilocybin Gummies & New Psychedelic Retreat: Rose Hill's New Offer
Tickers MYCOF
Tags Psilocybin program Benzinga Rose Hill
From Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.